Partners of the NoCanTher Consortium have attended the NanoMed Europe 2019 (NME19), the joint event of the 14th annual event of the Nanomedicine European Technology Platform (ETPN) & the European scientific conference ENM. NME19 is targeted to scientists, clinicians and actors from the industrial sector to discover and share nanomedical innovations, pitch the SMEs and initiate or consolidate H2020 and EuroNanoMed projects. The event has been held in Braga (Portugal) from June 17th-19th.
In the picture (left to right) Eusebio Gainza (BioKeralty), Ibane Abasolo, Simo Schwartz (VHIR), Heico Frima (EU project officer), Álvaro Somoza (IMDEA Nanociencia), Ángel del Pozo (BioKeralty) y Nuria Lafuente (IMDEA Nanociencia).
Dr. Simó Schwartz, from Vall d'Hebron Institute of Research, and Nuria Lafuente, from IMDEA Nanociencia, contributed with two talks to the discussion on magnetic nanoparticles for the diagnosis and treatment of pancreatic cancer.